TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 27881551

Group type: EXPERIMENTAL
Intervention: CR‐Equipements™ solid ankle cushion heel foot with polypropylene keel
Number of subjects: 15

Group type: COMPARATOR
Intervention: solid ankle cushion heel foot with wooden keel (Otto Bock)
Number of subjects: 15
Study: 26177352

Group type: EXPERIMENTAL
Intervention: Nonoxynol-9 (N9) gel
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Universal placebo gel (UPG)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control (nothing)
Number of subjects: 27
Study: 23022105

Group type: EXPERIMENTAL
Intervention: Laser-sintered Co-Cr (LS)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Vacuum-cast Co-Cr (CC)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Vacuum-cast Ni-Cr-Ti (CN)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: GC Fuji PLUS (FP)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: DentoTemp (DT)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Clearfil Esthetic Cement (CEC)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: RelyX Unicem 2 Automix (RXU)
Number of subjects: 45
Study: 22229185

Group type: EXPERIMENTAL
Intervention: Rivaroxaban 10 mg/d
Number of subjects: 119

Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 119
Study: 18927254

Group type: EXPERIMENTAL
Intervention: Autologous chondrocyte implantation
Number of subjects: 154

Group type: COMPARATOR
Intervention: Subsequent surgical procedures
Number of subjects: 154
Study: 17467059

Group type: EXPERIMENTAL
Intervention: Nefazodone
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Nefazodone in combination with interpersonal psychotherapy (IPT)
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: IPT in combination with placebo
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: IPT alone
Number of subjects: 193

Group type: COMPARATOR
Intervention: Control group (placebo with IPT)
Number of subjects: 193
Study: 15641632

Group type: EXPERIMENTAL
Intervention: Pycnogenol
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 11719944

Group type: EXPERIMENTAL
Intervention: Ndu tea extract
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Lipton tea extract
Number of subjects: 30

Group type: COMPARATOR
Intervention: Minty Brett (thymol 0.047%)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Combination of tea extracts with sodium lauryl sulfate (1.2% w/v)
Number of subjects: 30
Study: 9207726

Group type: EXPERIMENTAL
Intervention: Budesonide nasal spray, 50 micrograms to each nostril, bid for 3 weeks
Number of subjects: 151

Group type: COMPARATOR
Intervention: Placebo nasal spray, bid for 3 weeks
Number of subjects: 151
Study: 8432773

Group type: EXPERIMENTAL
Intervention: Recombinant human GH (0.25-0.5 U/kg.week, administered sc daily at bedtime)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Recombinant human GH
Number of subjects: 10
Study: 3435129

Group type: EXPERIMENTAL
Intervention: Intravenous cefodizime (1 g)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Intramuscular cefodizime (1 g)
Number of subjects: 6
Study: 29520947

Group type: COMPARATOR
Intervention: Negative partner control provided by women (T0)
Number of subjects: 113

Group type: COMPARATOR
Intervention: Negative partner control provided by men (T0)
Number of subjects: 113

Group type: COMPARATOR
Intervention: Negative partner control provided by partners (T2)
Number of subjects: 113
Study: 26890440

Group type: EXPERIMENTAL
Intervention: Postpartum antibiotic prophylaxis
Number of subjects: 80

Group type: COMPARATOR
Intervention: No treatment following delivery
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Post-CD antibiotics (meta-analysis)
Number of subjects: 80

Group type: COMPARATOR
Intervention: No treatment (meta-analysis)
Number of subjects: 80
Study: 25124305

Group type: EXPERIMENTAL
Intervention: Δ(9)‐THC (30 mg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Diazepam (5 mg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Diazepam (10 mg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Diazepam (5 mg) + Δ(9)‐THC (5, 15, 30 mg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Diazepam (10 mg) + Δ(9)‐THC (5, 15, 30 mg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 22562732

Group type: EXPERIMENTAL
Intervention: High-intensity training sessions (Group A) for the first 6 weeks of a 12-week training program.
Number of subjects: 43

Group type: COMPARATOR
Intervention: Low-intensity training (Group B) for the first 6 weeks of a 12-week training program.
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Both groups allowed to conduct high-intensity training in the second 6-week period.
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Incremental laboratory test measuring GE and V˙O2max.
Number of subjects: 43
Study: 20352087

Group type: EXPERIMENTAL
Intervention: Community-based maternal and newborn interventions including two antenatal home visits and four postnatal home visits by community health workers.
Number of subjects: 9987

Group type: COMPARATOR
Intervention: Control group (comparison arm) with no specific intervention mentioned.
Number of subjects: 9987
Study: 18794654

Group type: EXPERIMENTAL
Intervention: Agomelatine (25-50 mg/d)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 121
Study: 16320437

Group type: EXPERIMENTAL
Intervention: Gender-specific computer intervention (GSI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional intervention
Number of subjects: 0
Study: 12192263

Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Weight loss
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Education
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Inserts
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Footwear
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bracing
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Therapeutic ultrasound
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pulsed electromagnetic field therapy
Number of subjects: 0
Study: 10642057

Group type: EXPERIMENTAL
Intervention: L-carnitine (100 mg/kg per 24 h per os)
Number of subjects: 230

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 230
Study: 7775065

Group type: EXPERIMENTAL
Intervention: Morning spelling instruction
Number of subjects: 113

Group type: COMPARATOR
Intervention: Afternoon spelling instruction
Number of subjects: 113
Study: 2150366

Group type: EXPERIMENTAL
Intervention: Streptokinase
Number of subjects: 33

Group type: COMPARATOR
Intervention: r-TPA
Number of subjects: 33
Study: 493093

Group type: EXPERIMENTAL
Intervention: acebutolol
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: acebutolol in combination with a diuretic
Number of subjects: 34

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 34
Study: 31272901

Group type: EXPERIMENTAL
Intervention: Relocation pharyngoplasty with platelet-rich fibrin (PRF)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Classic relocation pharyngoplasty
Number of subjects: 30
Study: 31185905

Group type: EXPERIMENTAL
Intervention: Ultrasound guidance (group U)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Nerve stimulator guidance (group N)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Dual guidance (group M)
Number of subjects: 300
Study: 28035445

Group type: EXPERIMENTAL
Intervention: Progressive high-impact exercise
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 80
Study: 25858497

Group type: EXPERIMENTAL
Intervention: Masitinib plus gemcitabine (masitinib 9 mg/kg/day, gemcitabine 1000 mg/m²)
Number of subjects: 353

Group type: COMPARATOR
Intervention: Placebo plus gemcitabine (placebo, gemcitabine 1000 mg/m²)
Number of subjects: 353

Group type: EXPERIMENTAL
Intervention: Masitinib plus gemcitabine in ACOX1 subgroup
Number of subjects: 353

Group type: EXPERIMENTAL
Intervention: Masitinib plus gemcitabine in pain subgroup (VAS > 20 mm)
Number of subjects: 353
Study: 22647197

Group type: EXPERIMENTAL
Intervention: 12-week leadership intervention (workshop, teleconferences)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 0
Study: 20727239

Group type: EXPERIMENTAL
Intervention: Oral calcium and vitamin D supplementation for low bone density (LBD) women.
Number of subjects: 56
Study: 19386548

Group type: EXPERIMENTAL
Intervention: Standard-dose PCI (25 Gy in 10 daily fractions of 2.5 Gy)
Number of subjects: 720

Group type: COMPARATOR
Intervention: Higher-dose PCI (36 Gy delivered using either conventional or accelerated hyperfractionated radiotherapy)
Number of subjects: 720

Group type: EXPERIMENTAL
Intervention: Standard-dose PCI (25 Gy)
Number of subjects: 720

Group type: COMPARATOR
Intervention: Higher-dose PCI (36 Gy)
Number of subjects: 720
Study: 17240089

Group type: EXPERIMENTAL
Intervention: DHA-supplemented infant formula
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: DHA+ARA-supplemented infant formula
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control formula
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Breast-fed group
Number of subjects: 52
Study: 14597156

Group type: EXPERIMENTAL
Intervention: Folic acid alone (group A)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Folic acid plus Vitamin E (group B)
Number of subjects: 30
Study: 11294370

Group type: EXPERIMENTAL
Intervention: GW420867X 10 mg
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: GW420867X 50 mg
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: GW420867X 100 mg
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: GW420867X 200 mg
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 9827320

Group type: EXPERIMENTAL
Intervention: CSA prevention workshop
Number of subjects: 45

Group type: COMPARATOR
Intervention: Workshop on home safety (control)
Number of subjects: 45
Study: 7924362

Group type: EXPERIMENTAL
Intervention: High-frequency oscillatory ventilation
Number of subjects: 70

Group type: COMPARATOR
Intervention: Conventional mechanical ventilation
Number of subjects: 70
Study: 2486952

Group type: EXPERIMENTAL
Intervention: C-Reactive Protein (CRP) levels determined by nephelometric technique
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no PRM, infection, autoimmune diseases, or chronic inflammation)
Number of subjects: 30
Study: 795190

Group type: EXPERIMENTAL
Intervention: 0.1% diflucortolone valerate ointment
Number of subjects: 52

Group type: COMPARATOR
Intervention: 0.2% flumethasone ointment
Number of subjects: 52
Study: 31318772

Group type: EXPERIMENTAL
Intervention: Enhanced recovery program
Number of subjects: 150
Study: 29349868

Group type: EXPERIMENTAL
Intervention: Comprehensive alcohol harm reduction intervention
Number of subjects: 100

Group type: COMPARATOR
Intervention: Comparison group (control)
Number of subjects: 100
Study: 27378134

Group type: COMPARATOR
Intervention: Chronic inflammation
Number of subjects: 4109

Group type: COMPARATOR
Intervention: Acute inflammation
Number of subjects: 4109
Study: 24488743

Group type: EXPERIMENTAL
Intervention: Foster care group
Number of subjects: 89

Group type: COMPARATOR
Intervention: Care as usual group
Number of subjects: 89

Group type: COMPARATOR
Intervention: Never-institutionalized group (NIG)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Children with a history of institutional care
Number of subjects: 89
Study: 22251106

Group type: EXPERIMENTAL
Intervention: Remifentanil at an effect-site concentration of 4.0 ng.ml(‐1) with maximal flow rate limited to 100 ml.h(‐1) (group R(100))
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Remifentanil at an effect-site concentration of 4.0 ng.ml(‐1) with maximal flow rate limited to 200 ml.h(‐1) (group R(200))
Number of subjects: 210

Group type: COMPARATOR
Intervention: Remifentanil at an effect-site concentration of 4.0 ng.ml(‐1) with maximal flow rate limited to 1200 ml.h(‐1) (group R(1200))
Number of subjects: 210
Study: 20572767

Group type: EXPERIMENTAL
Intervention: ω‐3 group (SRP + dietary supplementation of fish oil 900 mg EPA + DHA + 81 mg aspirin daily)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (SRP + placebo)
Number of subjects: 80
Study: 18020853

Group type: EXPERIMENTAL
Intervention: Interactive distraction via a virtual reality head-mounted display helmet
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Passive distraction via a virtual reality head-mounted display helmet
Number of subjects: 40

Group type: COMPARATOR
Intervention: No distraction (control group)
Number of subjects: 40
Study: 16082528

Group type: EXPERIMENTAL
Intervention: Losartan treatment
Number of subjects: 1513

Group type: EXPERIMENTAL
Intervention: Losartan treatment in patients with LVH
Number of subjects: 1513
Study: 12692485

Group type: EXPERIMENTAL
Intervention: Silicone hydrogel lenses (30-night extended-wear)
Number of subjects: 139

Group type: COMPARATOR
Intervention: Conventional hydrogel lenses (6-night extended-wear)
Number of subjects: 139
Study: 10609973

Group type: EXPERIMENTAL
Intervention: Alprazolam
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 8542098

Group type: COMPARATOR
Intervention: Specialist journals (206 reports)
Number of subjects: 287

Group type: COMPARATOR
Intervention: General medical journals (81 reports)
Number of subjects: 287

Group type: COMPARATOR
Intervention: Unrestricted randomization in specialist journals
Number of subjects: 287

Group type: COMPARATOR
Intervention: Hypothesis tests in specialist journals
Number of subjects: 287

Group type: COMPARATOR
Intervention: Hypothesis tests in general journals
Number of subjects: 287
Study: 1826569

Group type: EXPERIMENTAL
Intervention: Monophasic oral contraceptive containing 30 micrograms ethinyloestradiol and 150 micrograms desogestrel (Marvelon, group A)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Triphasic oral contraceptive containing 30-40 micrograms ethinyloestradiol and 50-125 micrograms levonorgestrel (Triphasil, group B)
Number of subjects: 60
Study: 6791209

Group type: EXPERIMENTAL
Intervention: Scopolamine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study: 6149538

Group type: EXPERIMENTAL
Intervention: Almitrine bismesylate 100 mg/day in two divided doses
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 30997816

Group type: EXPERIMENTAL
Intervention: Depot medroxyprogesterone acetate (DMPA)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Oral contraceptive pills (OCPs)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Hormonal contraceptives (HCs)
Number of subjects: 74
Study: 29059542

Group type: EXPERIMENTAL
Intervention: Dance Movement Therapy (DMT)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 121
Study: 27858846

Group type: EXPERIMENTAL
Intervention: L + D group (fractional CO2 laser + luliconazole 1% cream)
Number of subjects: 60

Group type: COMPARATOR
Intervention: L group (fractional CO2 laser alone)
Number of subjects: 60
Study: 25171741

Group type: EXPERIMENTAL
Intervention: Maternal hookworm
Number of subjects: 2345

Group type: COMPARATOR
Intervention: Maternal hookworm absence
Number of subjects: 2345

Group type: EXPERIMENTAL
Intervention: Maternal hookworm presence
Number of subjects: 2345

Group type: COMPARATOR
Intervention: Maternal history of eczema absence
Number of subjects: 2345

Group type: EXPERIMENTAL
Intervention: Maternal history of eczema presence
Number of subjects: 2345

Group type: COMPARATOR
Intervention: Female gender absence
Number of subjects: 2345

Group type: EXPERIMENTAL
Intervention: Female gender presence
Number of subjects: 2345

Group type: EXPERIMENTAL
Intervention: Childhood Trichuris trichiura and hookworm
Number of subjects: 2345
Study: 22788235

Group type: EXPERIMENTAL
Intervention: Workshop intervention
Number of subjects: 6579

Group type: EXPERIMENTAL
Intervention: Telephone-interview intervention
Number of subjects: 6579

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 6579
Study: 20847065

Group type: EXPERIMENTAL
Intervention: Late remote ischaemic preconditioning (L‐RIPC) consisting of three five-minute cycles of upper limb ischaemia and three five-minute pauses using blood pressure cuff inflation 18 hours prior to the operation.
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Tramadol 200 mg retard administered at 19:00 hours the day before the operation and at 06:00 hours on the day of the operation.
Number of subjects: 101

Group type: COMPARATOR
Intervention: Control group (no intervention specified).
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Late remote ischaemic preconditioning (L‐RIPC).
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Tramadol group.
Number of subjects: 101
Study: 17624688

Group type: EXPERIMENTAL
Intervention: Abstinence reinforcement (AR)
Number of subjects: 368

Group type: EXPERIMENTAL
Intervention: New Uses of cocaine (measured by algorithm to BE)
Number of subjects: 368

Group type: COMPARATOR
Intervention: Qualitative urinalysis
Number of subjects: 368

Group type: COMPARATOR
Intervention: Benzoylecgonine concentration (BE)
Number of subjects: 368
Study: 16126652

Group type: EXPERIMENTAL
Intervention: Light therapy
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 12843894

Group type: EXPERIMENTAL
Intervention: Brimonidine tartrate 0.2% drops twice the day before and twice on the day of the operation
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 10403222

Group type: EXPERIMENTAL
Intervention: Lamotrigine (LTG) monotherapy
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 1957331

Group type: EXPERIMENTAL
Intervention: Intravenous (i.v.) administration of 0.6 mg digoxin
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Intravenous (i.v.) administration of 1.2 mg digoxin
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Oral (p.o.) administration of 0.6 mg digoxin
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Oral (p.o.) administration of 1.2 mg digoxin
Number of subjects: 3
Study: 6313028

Group type: EXPERIMENTAL
Intervention: Theophylline (6 mg/kg) while standing
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Theophylline (6 mg/kg) while supine
Number of subjects: 6

Group type: COMPARATOR
Intervention: Saline (placebo) while standing
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Theophylline (6 mg/kg) while standing vs supine
Number of subjects: 6
Study: 31488373

Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 1800

Group type: COMPARATOR
Intervention: Coronary artery bypass grafting (CABG)
Number of subjects: 1800

Group type: EXPERIMENTAL
Intervention: PCI in patients with three-vessel disease
Number of subjects: 1800

Group type: COMPARATOR
Intervention: CABG in patients with three-vessel disease
Number of subjects: 1800

Group type: EXPERIMENTAL
Intervention: PCI in patients with left main coronary artery disease
Number of subjects: 1800

Group type: COMPARATOR
Intervention: CABG in patients with left main coronary artery disease
Number of subjects: 1800
Study: 29359722

Group type: EXPERIMENTAL
Intervention: Cytoflavin
Number of subjects: 62

Group type: COMPARATOR
Intervention: Standard infusion therapy (Control)
Number of subjects: 62
Study: 24965957

Group type: EXPERIMENTAL
Intervention: Pilates method with NSAID treatment
Number of subjects: 60

Group type: COMPARATOR
Intervention: NSAID treatment without Pilates
Number of subjects: 60
Study: 23818768

Group type: EXPERIMENTAL
Intervention: Daily antioxidant and essential polyunsaturated fatty acid supplement (two pills) for 3 months (+S)
Number of subjects: 97

Group type: COMPARATOR
Intervention: No supplementation (‐NS)
Number of subjects: 97
Study: 19863602

Group type: EXPERIMENTAL
Intervention: Collagen-fibrin glue
Number of subjects: 29

Group type: COMPARATOR
Intervention: Collagen implant
Number of subjects: 29
Study: 19995507

Group type: EXPERIMENTAL
Intervention: Experienced operator with experienced assistant using rubber dam tooth-isolation method
Number of subjects: 804

Group type: COMPARATOR
Intervention: Inexperienced operator with inexperienced assistant
Number of subjects: 804

Group type: EXPERIMENTAL
Intervention: Experienced operator with inexperienced assistant
Number of subjects: 804

Group type: EXPERIMENTAL
Intervention: Experienced assistant with inexperienced operator
Number of subjects: 804
Study: 17535134

Group type: EXPERIMENTAL
Intervention: Visual imagery task
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Olfactory imagery task
Number of subjects: 186

Group type: COMPARATOR
Intervention: Auditory imagery task
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Nonimagery craving induction (chocolate deprivation and exposure to chocolate cues)
Number of subjects: 186
Study: 15470881

Group type: EXPERIMENTAL
Intervention: Reactmer (RM) - giomer
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Fuji II (FJ) - conventional glass ionomer
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Fuji II LC (FL) - resin modified glass ionomer
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Dyract AP (DY) - compomer
Number of subjects: 75

Group type: COMPARATOR
Intervention: Spectrum TPH (SP) - non-fluoride releasing composite
Number of subjects: 75
Study: 11425834

Group type: EXPERIMENTAL
Intervention: Oral misoprostol (400 microg)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo (vitamin B(6))
Number of subjects: 37
Study: 11720628

Group type: EXPERIMENTAL
Intervention: Enhanced external counterpulsation (EECP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard medical and surgical therapy
Number of subjects: 0
Study: 7592200

Group type: EXPERIMENTAL
Intervention: Running below lactate threshold (LT)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Running above lactate threshold (LT)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Running above LT
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Running below LT
Number of subjects: 24
Study: 1848972

Group type: EXPERIMENTAL
Intervention: Radiation therapy
Number of subjects: 213

Group type: COMPARATOR
Intervention: Mastectomy
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: Overall survival
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: Comedocarcinoma
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: Noncomedocarcinoma
Number of subjects: 213
Study: 7048915

Group type: EXPERIMENTAL
Intervention: Acyclovir applied topically four times daily for 10 days
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo applied topically four times daily for 10 days
Number of subjects: 43
Study: 31511385

Group type: EXPERIMENTAL
Intervention: V160 vaccine
Number of subjects: 6